Salesforce and Nippon Life helped take the business card management platform's funding to more than $36m since 2009.

Lodo Therapeutics has been launched by investment firm Accelerator Corporation with series A capital from investors including AbbVie, Eli Lilly, Wuxi PharmaTech, Pfizer, IBM and Johnson & Johnson.

Aelix Therapeutics will use the $12.7m of funding to advance its HIV vaccine candidate through phase 2 clinical trials.

Columbia University spinout Quartzy raises $17m in its series B round to recruit more staff and improve its lab management platform.

Pi-Cardia will use the funding to complete development of the next generation of its aortic valve stenosis treatment technology.

The paediatric care startup raised the cash in a series B round featuring real estate developer Longfor Properties.

The gig crowdsourcing platform raised $10m in a SoftBank Ventures Korea-led round that will support international growth.

The startup, which is developing treatments for Alzheimer's disease, received the money in a Pfizer-led round that also included Takeda's corporate venturing unit.

Neurological therapeutics developer Rodin took its overall funding to more than $30m after securing financing from Biogen and co-founder Atlas Venture.

Video broadcasting app Inke has received $10m from the gaming company, which picked up an 18% stake in return for its investment.